WEHAND
WeHand is a biopharmaceutical company focusing on the development of hypoglycemic drugs.
WEHAND
Social Links:
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2010-05-07
Address:
Daxing, Beijing, China
Country:
China
Website Url:
http://www.wehand-bio.cn
Total Employee:
1+
Status:
Active
Contact:
010-89285047
Total Funding:
33 M CNY
Technology used in webpage:
Alibaba Cloud MailBox
Current Employees Featured
Founder
Investors List
Lang Sheng Investment
Lang Sheng Investment investment in Series B - WeHand
Northern Light Venture Capital
Northern Light Venture Capital investment in Series B - WeHand
Lang Sheng Investment
Lang Sheng Investment investment in Series A - WeHand
Lapam Capital
Lapam Capital investment in Series A - WeHand
Cowin Capital
Cowin Capital investment in Series A - WeHand
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - WeHand
Lang Sheng Investment
Lang Sheng Investment investment in Angel Round - WeHand
More informations about "WeHand"
WeHand - Crunchbase Company Profile & Funding
WeHand is a biopharmaceutical company that focuses on innovative drugs for major diseases such as metabolic diseases, malignant tumors, anti-inflammatory immunity, and so on. …See details»
北京五和博澳药业股份有限公司
成立于2010年，位于中国药谷-北京大兴生物医药产业基地，系国家高新技术企业、北京市生物医药g20和中关村重大前沿原创高精尖企业。 公司专注于全球独家、高技术壁垒的原创新药。立 …See details»
Beijing Wehand-Bio Pharmaceutical Co., Ltd. (北京五和博澳药业股 …
了解Beijing Wehand-Bio Pharmaceutical Co., Ltd. (北京五和博澳药业股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 18篇新闻和13篇文献，疾病领域:肿瘤，内 …See details»
WeHand-Bio Company Profile 2024: Valuation, Funding
WeHand-Bio General Information Description. Provider of drug research and development services intended to focus on the treatment of diabetic diseases. The company creates drugs …See details»
Beijing Wehand-Bio Pharmaceutical Co., Ltd. - Drug pipelines, …
Explore Beijing Wehand-Bio Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 13 literature, Disease Domain:Neoplasms, …See details»
Beijing Wehand-Bio Pharmaceutical Co.，Ltd - cnverify.com
Beijing Wehand-Bio Pharmaceutical Co.，Ltd Country: China. Legal Representative: Huang Yuesheng. Business status: Active . Industry: Chinese patent medicine production. Company …See details»
Wehand-Bio - Products, Competitors, Financials, Employees, …
Use the CB Insights Platform to explore Wehand-Bio's full profile. Wehand-Bio - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
Beijing Wehand-bio Pharmaceutical Co.,Ltd - preqin.com
Based in Beijing, China and established in 2010, Beijing Wehand-bio Pharmaceutical Co.,Ltd focuses on developing and manufacturing medicine for curing diabet...See details»
中国临床试验注册中心 - 世界卫生组织国际临床试验注册平台一级 …
Beijing Wehand-Bio Pharmaceutical Co., LtD. Address： 30 Tianfu Street, Daxing Biomedicine Industrial BaseSee details»
Stronger cooperation between Chinese and Western medicine urged
Nov 30, 2024 By Zheng Yiran | chinadaily.com.cn | Updated: 2020-09-22 10:56 A staff member of a hospital fills prescriptions of traditional Chinese medicine for patients, May 26, 2019. …See details»
GUANGXI WEHAND-BIO PHARMACEUTICAL CO., LTD - US Patent …
GUANGXI WEHAND-BIO PHARMACEUTICAL CO., LTD - Hechi, Guangxi CN *profile and listings may contain filings by different individuals or companies with the same name. Review …See details»
Beijing Wehand - Company Profile - Tracxn
Beijing Wehand - Natural product based medicines for diabetes, oncology, and hypertension. from 3 investors. Beijing Wehand has 268 competitors.See details»
Beijing Wehand - Raised Funding from 3 investors - Tracxn
Beijing Wehand funding & investors. Natural product based medicines for diabetes, oncology, and hypertension. 2010 • Beijing (China) • Funding Raised • Beijing (China) • Funding RaisedSee details»
Mulberry twig alkaloids - Drug Targets, Indications, Patents
Beijing Wehand-Bio Pharmaceutical Co., Ltd. Chinese Academy of Medical Scciences & Peking Union Medical College Active Organization Guangxi Wuhe Boao Pharmaceutical Co., Ltd. …See details»
WH-002 - Drug Targets, Indications, Patents - Synapse - Patsnap
WH-002: a Tubulin inhibitors Drug, Initially developed by Beijing Wehand-Bio Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 1, Mechanism: Tubulin inhibitors, …See details»
五和博澳药业 · 北京五和博澳药业有限公司 · Current.VC
五和博澳药业 北京五和博澳药业有限公司See details»
A Perfect "Snapshot" of Beijing's New Productive Forces and ...
Jun 7, 2024 "In the future, we will continue to optimize our R&D system," emphasized Jin Yiqun, Director and Executive Deputy General Manager of Beijing WeHand Bio Pharmaceutical Co., …See details»
WeHand - Contacts, Employees, Board Members, Advisors
Organization. WeHand . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. WeHand has 1 …See details»
Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of …
3 Beijing Wehand-bio Pharmaceutical Co. Ltd., Beijing, 100260, People's Republic of China. 4 State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of …See details»
实验：健康受试者单剂量桑枝生物碱片 126 mg 和 健康受试者单剂 …
Jun 18, 2024 该试验在中国进行。 该试验的目的是研究桑枝生物碱片（wh006）在健康、超重和肥胖受试者中的安全性、耐受性和药代动力学。。临床试验注册。 ich gcp。See details»